Related Experiment Video
Updated: Jan 31, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products
Lindsey R Drake1, Peter J H Scott1
1Departments of Radiology and Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
The receptor for advanced glycation end-products (RAGE) is implicated in multiple disease states such as cancer, diabetes and neurodegenerative disorders, and RAGE inhibitors are being explored as potential new therapies in such cases. Despite the known role RAGE plays in these conditions, there remains an urgent need for a molecular imaging agent that can accurately quantify RAGE levels in vivo, aid in validation of RAGE as a biomarker and/or therapeutic target, and support development of new RAGE inhibitors. This editorial highlights a multimodal nanoparticle-based imaging agent targeted at RAGE that was recently developed by Konopka and colleagues (Theranostics 2018; 8(18):5012-5024. doi:10.7150/thno.24791).
Insights
A new multimodal nanoparticle imaging agent targets the receptor for advanced glycation end-products (RAGE). This tool aids in quantifying RAGE levels in vivo, supporting RAGE-targeted therapies and inhibitor development.
Area of Science:
- Biomedical imaging
- Nanotechnology
- Molecular biology
Background:
- Receptor for advanced glycation end-products (RAGE) is linked to diseases like cancer, diabetes, and neurodegeneration.
- RAGE inhibitors are under investigation as novel therapeutic strategies.
- Accurate in vivo quantification of RAGE is crucial for biomarker validation and drug development.
Discussion:
- This editorial reviews a novel multimodal nanoparticle-based imaging agent designed to target RAGE.
- The agent facilitates in vivo RAGE quantification, addressing a critical unmet need in RAGE-related disease research.
- This development supports the validation of RAGE as a therapeutic target and aids in the advancement of RAGE inhibitor therapies.
Key Insights:
- A multimodal nanoparticle imaging agent for RAGE has been developed.
- This agent enables accurate in vivo quantification of RAGE levels.
- It serves as a valuable tool for RAGE biomarker validation and RAGE inhibitor development.
Outlook:
- The developed imaging agent holds promise for advancing RAGE-targeted therapies.
- It can accelerate the clinical translation of RAGE inhibitors.
- Further research may explore its application in various RAGE-associated pathologies.
Related Concept Videos
Internal Receptors
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors

